ADVFN Logo
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

CMMB Chemomab Therapeutics Ltd

0.6011
-0.0288 (-4.57%)
Feb 20 2024 - Closed
Delayed by 15 minutes
Company Name Stock Ticker Symbol Market Type
Chemomab Therapeutics Ltd CMMB NASDAQ Depository Receipt
  Price Change Change Percent Stock Price Last Traded
-0.0288 -4.57% 0.6011 19:59:05
Open Price Low Price High Price Close Price Prev Close
0.67 0.551 0.7122 0.67 0.6299
more quote information »

Recent News

Date Time Source Heading
2/20/202409:20APSBiotech Shares Massively Bid Up Before Opening Bell
2/20/202407:00PRNUSChemomab Awarded New Patents for CM-101, Its First-in Class..
2/14/202407:00PRNUSChemomab Therapeutics to Report Fourth Quarter and Full Year..
2/05/202407:00PRNUSChemomab Therapeutics to Participate in Upcoming Investor..
1/30/202407:00PRNUSChemomab Therapeutics Announces New Publication Reinforcing..
1/03/202407:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
1/03/202407:00PRNUSChemomab Announces Completion of Patient Enrollment in..
11/16/202307:00PRNUSChemomab Presentation at ACR Convergence 2023 Provides..
11/15/202316:35EDGAR2Form SC 13D/A - General statement of acquisition of..
11/15/202307:00PRNUSChemomab Therapeutics Receives FDA Fast Track Designation..
11/13/202308:00PRNUSChemomab Presents New Clinical Data Supporting CM-101's..
11/09/202308:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11/09/202308:00PRNUSChemomab Therapeutics Announces Third Quarter 2023 Financial..
11/06/202316:15PRNUSChemomab Therapeutics Discloses Receipt of Nasdaq Notice..
11/06/202300:15EDGAR2Form EFFECT - Notice of Effectiveness
10/30/202308:33EDGAR2Form F-3/A - Registration statement by foreign private..
10/30/202307:00PRNUSChemomab Therapeutics to Report Third Quarter 2023 Financial..
10/26/202307:00PRNUSChemomab Therapeutics to Present at Upcoming Scientific..
10/16/202316:25EDGAR2Form F-3 - Registration statement by foreign private issuers
9/28/202307:00PRNUSChemomab Therapeutics to Present Its CM-101 Clinical Program..
8/29/202307:00PRNUSChemomab Therapeutics to Present at the H.C. Wainwright 25th..
8/14/202308:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
8/14/202308:00PRNUSChemomab Therapeutics Announces Second Quarter 2023..
8/08/202306:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
7/05/202317:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
7/03/202315:49EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
6/28/202307:00PRNUSChemomab Therapeutics Announces Publication in JCI Insight..
6/26/202307:00PRNUSChemomab Therapeutics Presents Data Reinforcing the Clinical..
6/21/202307:00PRNUSChemomab Therapeutics Reports Positive Data from Secondary..
6/05/202307:00PRNUSChemomab Therapeutics Announces Executive Leadership Changes..
6/02/202309:00PRNUSPatient Data Presented at 2023 EULAR Congress Highlights How..
5/24/202307:00PRNUSChemomab Therapeutics to Participate in Upcoming Scientific..
5/11/202306:00PRNUSChemomab Therapeutics Announces First Quarter 2023 Financial..
4/26/202307:00PRNUSChemomab Therapeutics to Present at 2023 Aegis Virtual..
4/19/202307:00PRNUSChemomab Therapeutics to Present at Upcoming Scientific..
4/12/202307:00PRNUSChemomab Therapeutics to Discuss First Quarter 2023..
3/29/202308:30PRNUSChemomab Therapeutics to Provide a Corporate Update on April..
3/17/202307:00PRNUSChemomab Therapeutics to Discuss Fourth Quarter and..
3/06/202307:00PRNUSChemomab to Present at the Oppenheimer 33rd Annual..
2/21/202307:00PRNUSChemomab Announces FDA Clearance of Investigational New Drug..

Your Recent History

Delayed Upgrade Clock